Answers are grounded in this paper and cite their sources.
Host–microbe interactions involve four molecular layers with distinct measurement requirements and interpretive limits: inherited host variation, microbial gene content, host regulatory states, and acquired somatic mutations. This critical narrative review distinguishes these layers and evaluates evidence connecting host determinants, microbial functions, immune intermediaries, and clinical outcomes. Human associations, experimental mechanisms, and controlled interventions are assessed separately to identify established connections and unresolved links. Replicated microbiome genome-wide association studies implicate substrate availability, mucosal glycosylation, and epithelial function, although the mechanisms connecting associated variants to microbial traits often remain unresolved. Monogenic immune disorders establish causal relationships between defined genetic defects and immune dysfunction, but their microbial consequences are less consistently characterised in patients. Microbial metabolites influence receptor signalling and chromatin regulation through molecule-specific pathways supported predominantly by experimental studies. In inflammatory bowel disease, genetic susceptibility and longitudinal multi-omic findings support host–microbial interactions, while the direction and contribution of microbial changes remain unresolved. Colibactin induces mutations in human intestinal organoids, with corresponding mutational signatures identified in human colorectal cancers. Helicobacter pylori eradication reduces gastric cancer incidence in randomised trials, while microbiota-directed interventions prevent further recurrence of Clostridioides difficile infection. In autoimmune and reproductive disorders, microbial functions and immune intermediaries remain incompletely connected in humans. Oncology trials provide preliminary signals requiring controlled confirmation and assessment of microbial mediation. The persistence and functional consequences of microbially induced regulatory states across the human life course remain unresolved. Integrating strain-resolved, quantitative, and cell-specific measurements with longitudinal sampling and controlled interventions could clarify when microbial activity mediates host susceptibility, modifies disease, or reflects its consequences.
No takes yet. Share an insight, caveat, or question.
Ζαγοριανάκου et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: